Predicting BCG Response — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Predicting BCG Response — Stella

Recruiting

Back to Bladder Cancer trials

Trial locations(5 sites)

United States

Cedars-Sinai Medical Center, Los Angeles, California

UCLA, Los Angeles, California

UCSF, San Francisco, California

University of Texas Southwestern, Dallas, Texas

Japan

Kyoto University, Kyoto, Kyoto

Key details

Sponsor

Cedars-Sinai Medical Center

Collaborators

National Cancer Institute (NCI), Nonagen Bioscience Corporation

Enrollment target

~400 participants

Started

September 2020

Primary completion

February 2030

Age range

18 Years – 90 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov